Gene identified in 10% of multiple myeloma cases
Combining the number-crunching potency of computers with an exploration of the genetic code, scientists have identified a new master gene in cancer.
The research, published by separate teams in the journal Nature Genetics, could open up avenues to identify people at risk and, potentially, new drugs to block the mechanisms that let cancers proliferate, they hope.
British-based researchers said a gene called UTX, found in the X gender chromosome, played the role of ringmaster in 10 percent of cases of multiple myeloma and one in 12 cancers of the oesophagus.
UTX controls an enzyme that contributes to the structure of DNA in our cells. The enzyme also acts as a switch, turning other genes on and off.
In a massive genetic trawl through tissue samples from patients with a form of kidney cancer, the scientists found a rare but telling signature among a mutated form of UTX.
By expanding the search to other cancer types, they also found the variant gene played a part in multiple myeloma -- cancer of the immune cells -- and in throat tumours.
"It influences some of the most fundamental mechanisms controlling gene activity in our cells," said Andy Futreal, co-leader of the Cancer Genome Project at Britain's Wellcome Trust Sanger Institute, which led the study.
"Unlike many cancer genes, UTX does not appear to be directly involved in cell division or cell death but in basic regulation, and shows the depths to which cancers will plumb in order to get themselves ready to go."
The research, published by separate teams in the journal Nature Genetics, could open up avenues to identify people at risk and, potentially, new drugs to block the mechanisms that let cancers proliferate, they hope.
British-based researchers said a gene called UTX, found in the X gender chromosome, played the role of ringmaster in 10 percent of cases of multiple myeloma and one in 12 cancers of the oesophagus.
UTX controls an enzyme that contributes to the structure of DNA in our cells. The enzyme also acts as a switch, turning other genes on and off.
In a massive genetic trawl through tissue samples from patients with a form of kidney cancer, the scientists found a rare but telling signature among a mutated form of UTX.
By expanding the search to other cancer types, they also found the variant gene played a part in multiple myeloma -- cancer of the immune cells -- and in throat tumours.
"It influences some of the most fundamental mechanisms controlling gene activity in our cells," said Andy Futreal, co-leader of the Cancer Genome Project at Britain's Wellcome Trust Sanger Institute, which led the study.
"Unlike many cancer genes, UTX does not appear to be directly involved in cell division or cell death but in basic regulation, and shows the depths to which cancers will plumb in order to get themselves ready to go."
posted by gwg at 3:52 PM
0 Comments:
Post a Comment
<< Home